19-12840993-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The ENST00000251472.9(MAST1):āc.175A>Gā(p.Ser59Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000641 in 1,247,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000251472.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAST1 | NM_014975.3 | c.175A>G | p.Ser59Gly | missense_variant, splice_region_variant | 3/26 | ENST00000251472.9 | NP_055790.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAST1 | ENST00000251472.9 | c.175A>G | p.Ser59Gly | missense_variant, splice_region_variant | 3/26 | 1 | NM_014975.3 | ENSP00000251472 | P1 | |
MAST1 | ENST00000591495.6 | c.163A>G | p.Ser55Gly | missense_variant, splice_region_variant | 4/13 | 5 | ENSP00000466470 | |||
MAST1 | ENST00000590883.1 | n.275A>G | splice_region_variant, non_coding_transcript_exon_variant | 3/6 | 5 | |||||
HOOK2 | ENST00000589765.1 | n.33-14493T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151968Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000639 AC: 7AN: 1095450Hom.: 0 Cov.: 19 AF XY: 0.00000714 AC XY: 4AN XY: 560316
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74222
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 23, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with MAST1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 59 of the MAST1 protein (p.Ser59Gly). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at